SVB Leerink Maintains Market Perform on Radius Health, Raises Price Target to $24
SVB Leerink analyst Geoffrey Porges maintains Radius Health (NASDAQ:RDUS) with a Market Perform and raises the price target from $23 to $24.
Earnings Scheduled For May 7, 2021
Companies Reporting Before The Bell
• Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter.
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.